Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Eberle

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 15, 2020
[Rapid diagnosis of sexually transmitted infections : Joint statement of DSTIG, RKI, and PEI, as well as the reference centers for HIV, HBV, and HCV and consulting laboratories for Chlamydia, gonococci, and Treponema pallidum]Thomas Meyer, Josef Eberle, R Stefan Roß, et al.
Intervirology|January 31, 2012
HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledgeMartin Obermeier, Alejandro Pironti, Thomas Berg, et al.
Current HIV Research|December 31, 2016
HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Cross-sectional DesignAubin J Nanfack, Desire Takou, Joseph Fokam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2020
Human Immunodeficiency Virus-2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western EuropeDirk Berzow, Diane Descamps, Martin Obermeier, et al.
Emerging Infectious Diseases|September 18, 2020
Drug Resistance Spread in 6 Metropolitan Regions, Germany, 2001-2018<sup>1</sup>Melanie Stecher, Antoine Chaillon, Christoph Stephan, et al.
Scientific Reports|May 3, 2018
Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions - Cologne/Bonn, Munich and Hannover, 1999-2016Melanie Stecher, Antoine Chaillon, Josef Eberle, et al.
Current Research in Microbial Sciences|May 15, 2024
The search for an antiviral lead molecule to combat the neglected emerging Oropouche virusRafaela Dos Santos Peinado, Marielena Vogel Saivish, Gabriela de Lima Menezes, et al.
Transfusion|October 17, 2018
Human immunodeficiency virus 1 dual-target nucleic acid technology improves blood safety: 5 years of experience of the German Red Cross blood donor service Baden-Württemberg-HessenKai Hourfar, Josef Eberle, Markus Müller, et al.
The Pan African Medical Journal|February 23, 2026
Monitoring of virological response and acquired HIV-1 drug resistance among patients initiating antiretroviral therapy in the Centre Region of CameroonBello Djoda, Jerome Fru-Cho, Patrick Achiangia Njukeng, et al.
Current Research in Microbial Sciences|January 18, 2024
Acridones as promising drug candidates against Oropouche virusMarielena Vogel Saivish, Gabriela de Lima Menezes, Roosevelt Alves da Silva, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 15, 2020
[Rapid diagnosis of sexually transmitted infections : Joint statement of DSTIG, RKI, and PEI, as well as the reference centers for HIV, HBV, and HCV and consulting laboratories for Chlamydia, gonococci, and Treponema pallidum]Thomas Meyer, Josef Eberle, R Stefan Roß, et al.
Intervirology|January 31, 2012
HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledgeMartin Obermeier, Alejandro Pironti, Thomas Berg, et al.
Current HIV Research|December 31, 2016
HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Cross-sectional DesignAubin J Nanfack, Desire Takou, Joseph Fokam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2020
Human Immunodeficiency Virus-2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western EuropeDirk Berzow, Diane Descamps, Martin Obermeier, et al.
Emerging Infectious Diseases|September 18, 2020
Drug Resistance Spread in 6 Metropolitan Regions, Germany, 2001-2018<sup>1</sup>Melanie Stecher, Antoine Chaillon, Christoph Stephan, et al.
Scientific Reports|May 3, 2018
Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions - Cologne/Bonn, Munich and Hannover, 1999-2016Melanie Stecher, Antoine Chaillon, Josef Eberle, et al.
Current Research in Microbial Sciences|May 15, 2024
The search for an antiviral lead molecule to combat the neglected emerging Oropouche virusRafaela Dos Santos Peinado, Marielena Vogel Saivish, Gabriela de Lima Menezes, et al.
Transfusion|October 17, 2018
Human immunodeficiency virus 1 dual-target nucleic acid technology improves blood safety: 5 years of experience of the German Red Cross blood donor service Baden-Württemberg-HessenKai Hourfar, Josef Eberle, Markus Müller, et al.
The Pan African Medical Journal|February 23, 2026
Monitoring of virological response and acquired HIV-1 drug resistance among patients initiating antiretroviral therapy in the Centre Region of CameroonBello Djoda, Jerome Fru-Cho, Patrick Achiangia Njukeng, et al.
Current Research in Microbial Sciences|January 18, 2024
Acridones as promising drug candidates against Oropouche virusMarielena Vogel Saivish, Gabriela de Lima Menezes, Roosevelt Alves da Silva, et al.
Pageof 5